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Introduction 
Rapid, accurate diagnostic modalities for carbapenemase producing organisms (CPO) detection are 
needed.  Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectrometry (MALDI-TOF 
MS) has been shown to accurately and quickly identify CPOs compared to traditional methods.  In this 
study, we hypothesized that MALDI-TOF MS would accurately identify CPO with the following known 
mechanisms of resistance: KPC, VIM, NDM, IMI, IMP, OXA-48, and GES-16.   
Methods 
35 CPO, 3 beta-lactamases (GES-5, CMY-2, SHV-type ESBL) and 76 other non-carbapenemase producing 
organisms (nCPO) with no other known mechanisms of resistance were tested for carbapenemase 
production with microdilution, Etest®, and MALDI-TOF MS.  Degradation of any ertapenem specific peak 
(476 [M + H]+, 498 [M+ Na]+, and 520 [M + 2 Na]+) on MALDI-TOF MS was considered consistent with a 
CPO.  MALDI-TOF MS results were compared to Etest®, modified Hodge test, and microdilution 
(MicroScan [Beckman-Coulter] or Phoenix [Becton Dickinson]).   
Results 
All of the 76 nCPO had intact ertapenem peaks on MALDI-TOF MS.  2 of the nCPO, SHV-type ESBL 
K.pneumoniae and CMY-2 C.freundii, showed ertapenem degradation on MHT.  54.3% (19/35) of CPO 
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demonstrated degradation of all three ertapenem specific peaks on MALDI-TOF MS.  94.2% (33/35) of 
CPO demonstrated the absence of at least one peak.  MHT identified 100% of CPOs but was also positive 
for 2/3 beta-lactamase producing nCPO. Microdilution of ertapenem, imipenem, and meropenem 
identified 94.3%, 97.1%, and 91.4% of CPOs, respectively.  KPC-4 K.pneumoniae and IMP-18 
Ps.aeruginosa were detected by MHT but not MALDI-TOF MS.  Additional kinetic studies and sequence 
analysis are planned for these isolates. 1 of 3 KPC E. cloacae was not identified by MHT or microdilution 
and there was only degradation at the 520 peak on MALDI-TOF MS.   Specificity of our assay was 100%. 
Discussion  
CPO detection is difficult and may require multiple methods for accurate detection.   No method of 
detection identified all CPOs.  MALDI-TOF MS requires minimal time for CPO detection with same day 
turn around.  Procedures are also relatively simple and high-level training is not required.  Establishing 
standard procedures and interpretations will be necessary for clinical use. 
